Novartis 15. Mai 2026 Novartis, amid reorg, cuts ‘select number’ of biomedical research roles - Fierce Biotech
Novartis 12. Mai 2026 New prostate cancer hopes from Roche and Novartis | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Novartis 12. Mai 2026 Biotech and the Efficiency Revolution: Why the Final Mile Matters Most for Novartis, BioNTech, and BioNxt - news.financial
Novartis 7. Mai 2026 Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis - Fierce Biotech
Novartis 6. Mai 2026 Global pharma company Novartis plans $220-million RTP investment - Spectrum News
Novartis 5. Mai 2026 Biopharma bites: FDA withholds vaccine data, plus staffing cuts for Novartis, Gilead - FirstWord Pharma
Novartis 5. Mai 2026 Celcuity’s gedatolisib beats Novartis drug in Phase III test - The Pharma Letter
Novartis 4. Mai 2026 After March cuts, Novartis trims another 60 roles at US headquarters - Fierce Pharma
Novartis 4. Mai 2026 Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study - Fierce Biotech
Novartis 4. Mai 2026 Novartis Pharmaceuticals Announces $220 M Expansion in Morrisville - Wake County Government (.gov)
Novartis 30. Apr. 2026 Novartis finalizes US manufacturing and R&D expansion plan - The Pharma Letter
Novartis 30. Apr. 2026 Novartis to build Morrisville pharma facility as part of $23 billion push - CBS 17
Novartis 30. Apr. 2026 Novartis rounds out $23B US investment push with plans for North Carolina API plant - Fierce Pharma
Novartis 30. Apr. 2026 Novartis Reshapes Growth With Biotech Deals And AI Powered R&D Push - Yahoo Finance
Novartis 29. Apr. 2026 Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval - BioSpace